Lilly to acquire Kelonia Therapeutics for $3.25 billion to advance in vivo CAR-T cell therapies
On Apr. 20, 2026, Eli Lilly and Kelonia Therapeutics, a clinical-stage biotechnology company pioneering in vivo gene delivery,…
-
-
Kailera nets $625M, biotech’s biggest-ever IPO
On Apr. 17, 2026, Kailera Therapeutics, a high-profile drug startup aiming to compete with Novo Nordisk and Eli…
-
Cancer Center at Illinois Earns Prestigious National Cancer Institute Designation
On Apr. 16, 2026, the Cancer Center at Illinois (CCIL) announced it has been designated as a Basic…
-
Biotechnology | Diagnostics | Disease | Genomics | Oncology | Therapeutics
Roche Expands Foundation Medicine With Acquisition of SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease Platform for $595 million
On Apr. 15, 2026, Foundation Medicine, an independent affiliate of the Roche group, announced it is set to…
-
Amazon Bio Discovery Launches lab-in-the-loop drug discovery
On Apr. 14, 2026, Amazon announces launching AI BioDiscovery Contract Research Orgainzation. Lab-in-the-loop drug discovery has transformed research…
-
Scientists reverse brain aging, with a nasal spray
On Apr. 14, 2026, a landmark study from researchers at the Texas A&M University Naresh K. Vashisht College…
-
Novo Nordisk partners with OpenAI in weight loss drug race
On Apr. 14, 2026, Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI…
-
Hidden mutations in immune cells linked to autoimmune disease
On Apr. 14, 2026, researchers from the Wellcome Sanger Institute, Cambridge University Hospitals NHS Foundation Trust (CUH), the…
-
Biotechnology | CDC | Chemistry | Genomics
Hackers meet their match: New DNA encryption protects engineered cells from within
On Apr. 11, 2026, in Science Advances, a team of U.S. researchers present a new approach to genetically…
-
Genome loaded onto a quantum computer in world first
On Apr. 9, 2026, scientists from the Wellcome Sanger Institute and the Universities of Oxford, Cambridge and Melbourne,…
-
Biotechnology | Diagnostics | Genomics | Infectious Disease | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Trump administration drops court fight to cap NIH payments for research overhead costs
On Apr. 8, 2026, the Trump administration will not be asking the Supreme Court to take up its…
-
Gilead to Acquire Tubulis for $5 Billion to Further Strengthen Oncology Pipeline
On Apr. 7, 2026, Gilead Sciences announced it has entered into a definitive agreement to acquire Tubulis, a…
-
Cornell Scientists take big step toward safe, reversible male contraception
On Apr. 7, 2026, Cornell scientists announce they have taken a major step toward developing a safe, reversible,…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Medical Device | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
Life Science Industry’s Rapid Growth in Washington State Challenged by NIH Budget Cuts
On Apr. 7, 2026, LifeScienceHistory.com, formerly WashingtonLifeScience.com, announces release of a report highlighting the challenges of Washington State’s…
-
UCLA researchers develop low-cost blood test to detect multiple cancers and other diseases from a single sample
On Apr. 6, 2026, scientists from the University of California, Los Angeles (UCLA) announce they have developed a…
-
New microscopy technique reveals hidden magnetic chemistry in living systems
On Apr. 6, 2026, a research team at the University of Tokyo announced they have developed a new…
-
L’Oréal and Institut Pasteur announce historic partnership to advance skin health science
On Apr. 2, 2026, L’Oréal and the Institut Pasteur announced a landmark research partnership, marking a historic first…
-
Zhang Kai, Yale scientist leaves for China university
On Apr. 2, 2026, Zhang Kai, a rising cryo-electron microscopy researcher, has resigned from his tenure-track position at…
-
Johns Hopkins Team Develops Therapeutic, Nasally Delivered DNA Vaccine for Tuberculosis
On Apr. 1, 2026, a research team at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of…
-
FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
On Apr. 1, 2026, Eli Lilly announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for…
-
Artificial Intelligence | Biotechnology | Cloning | CRISPR | Diagnostics | Genomics | Implants | Infectious Disease | Life Science History | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Pharmaceutical | Quantum | Therapeutics | U.S. Congress
China Tops U.S. in R&D Spending
On Mar. 31, 2026, the Organisation for Economic Co-operation and Development (OECD), reports that China has officially crept…
-
Biogen to Acquire Apellis for $5.6 billion, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
-
Lilly to acquire Centessa Pharma to advance treatments for sleep-wake disorders in deal worth up to $7.8 Billion
On Mar. 31, 2026, Eli Lilly and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
-
Artificial Intelligence | Biotechnology | Diagnostics | Infectious Disease | Medical Device | Neurology | Pharmaceutical | Therapeutics
China biotech deals hit record as innovative drugs draw interest of multinationals
On Mar. 29, 2026, The South China Morning Post reported the cross-border outlicensing activities of Chinese biotech firms…
-
Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly
On Mar. 29, 2026, generative-AI drug developer Insilico Medicine announced that it has agreed to a global licensing…
-
Biotechnology | Clinical Research | Diagnostics | Environmental | Infectious Disease | NIH | Non-Profit Research | Rare Disease | Therapeutics | Vaccine
NIH restrictions on foreign research partnerships significantly impacted 1 in 4 U.S. scientists
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
-
Novartis to acquire Excellergy for $2 Billion, building on allergy leadership with next-generation anti-IgE innovation
On Mar. 27, 2026, Novartis announced an agreement to acquire Excellergy, a private biotech company developing next-generation anti-IgE…
-
Implantable ‘Living Pharmacy’ Produces Multiple Drugs Inside the Body
On Mar. 27, 2026, A multi-institutional team of scientists, co-led by Northwestern University, has taken a crucial step…
-
US measles cases top 1,500 as Texas outbreak grows
On Mar. 27, 2026, measles cases in the United States have climbed to 1,575, with 88 new infections,…
